Nocardiosis in renal transplant patients: Role of current immunosuppressant agents

Infectious Diseases in Clinical Practice

Volumn 15, Issue 3, 2007, Pages 171-173

  Vigil, Karen J ^a   Pasumarthy, Anita ^b   Johnson, Leonard B ^b   Sheppard, Theresa ^c   El Ghoroury, Mohammed ^b   Del Busto, Ramon ^a,c  

^a HENRY FORD HOSPITAL   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; BRAIN INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; EYE INFECTION; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION PREVENTION; INFECTIOUS ARTHRITIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; NOCARDIA ASTEROIDES; NOCARDIOSIS; RETROSPECTIVE STUDY; REVIEW; SHORT COURSE THERAPY; TREATMENT DURATION;

EID: 34249030640     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000269909.41735.27     Document Type: Review

References (14)

1. Horl MP, Schmitz M, Ivens K, et al. Opportunistic infections after renal transplantation. Curr Opin Urol. 2002;12:115-123.
2. Lerner PI. Nocardiosis. Clin Infect Dis. 1996;22:891-905.
3. Wilson JP, Turner HR, Kirchner KA, et al. Nocardia infections in renal transplant recipients. Medicine (Baltimore). 1989;68:38-57.
4. Arduino RC, Johnson PC, Miranda AG. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis. 1993;16:505-512.
5. Queipo-Zaragoza JA, Broseta-Rico E, Alapont-Alacreu JM, et al. Nocardia infection in immunosuppressed kidney transplant recipients. Scand J Urol Nephrol. 2004;38:168-173.
6. Vincenti F. A decade of progress in kidney transplantation. Transplantation. 2004;77(suppl 9):S52-S61.
7. Henry ML. Cyclosporine and tacrolimus (FK 506): a comparison of efficacy and safety profiles. Clin Transplant. 1999;13:209-220.
8. Bach MC, Adler JL, Breman J, et al. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet. 1973;27:180-184.
9. Kursat S, Ok E, Zeytinoglu A, et al. Nocardiosis in renal transplant patients. Nephron. 1997;75:370-371.
10. Fox P, Sollinger HW, Belzer FO, et al. Prospective randomized double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplant patients: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 1990;89:255-274.
11. Reddy SS, Holley JL. Nocardiosis in a recently transplanted renal patient. Clin Nephrol. 1998;50:123-127.
12. Wong KM, Chak WL, Chan YH, et al. Subcutaneous nodules attributed to nocardiosis in a renal transplant recipient on tacrolimus therapy. Am J Nephrol. 2000;20(2):138-141.
13. Magee CC, Halligan RD, Milford EL, et al. Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil. Clin Nephrol. 1999;52(1):44-46.
14. Canet S, Garrigue V, Bismuth J, et al. Nocardiosis - is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation? Nephrologie. 2004;25(2):43-48.